Cell & Gene Therapy Bioanalytical Testing Services Market, By Product Type (Cell Therapy, and Gene Therapy, and Gene-Modified Cell Therapy), By Test Type, By Technology, By Indication Coverage, By End User, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
REPORT HIGHLIGHT
Cell & Gene Therapy Bioanalytical Testing Services Market size was valued at US$ 560.90 Million in 2024, expanding at a CAGR of 7.90% from 2025 to 2032.
The Cell & Gene Therapy Bioanalytical Testing Services Market involves specialized analytical services essential for the development, characterization, and regulatory approval of cell and gene therapy products. Market growth is driven by the increasing number of clinical trials in regenerative medicine and personalized therapeutics. For example, as of early 2024, the FDA reported over 2,000 active Investigational New Drug (IND) applications for gene and cell therapy products. Significant investments from public health organizations, such as the NIH’s $500 million commitment to advance gene therapies for rare diseases, are further fueling demand. However, challenges including the complexity of assay development and high operational costs continue to restrain market expansion. Key opportunities exist in expanding testing capabilities for viral vectors, potency assays, and biodistribution studies, particularly as global regulatory agencies implement stricter guidelines for cell-based therapies. Moreover, collaborations between biopharmaceutical companies and contract research organizations (CROs) are helping streamline bioanalytical workflows, accelerating the time-to-market for next-generation therapies.
Cell & Gene Therapy Bioanalytical Testing Services Market- Market Dynamics
Increasing Clinical Trial Activity and Strengthened Regulatory Oversight to Drive Market Growth
The surge in clinical trial activity and heightened regulatory scrutiny have significantly boosted demand for cell and gene therapy bioanalytical testing services. In 2023, the U.S. FDA approved over 25 Investigational New Drug (IND) applications for gene therapies, highlighting the strong pipeline of therapies in development. Globally, governments are increasingly supporting these advancements; for example, the European Commission allocated €2 billion in 2023 toward regenerative medicine research, while China’s National Medical Products Administration (NMPA) accelerated approval pathways for cell and gene therapies. Additionally, regulatory agencies such as the European Medicines Agency (EMA) and Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) are requiring comprehensive bioanalytical validation to ensure safety and efficacy. Increased funding from organizations like the NIH and the California Institute for Regenerative Medicine (CIRM) for gene and cell therapy trials is further driving demand for specialized testing services. These developments underscore the essential role of precise analytical platforms in maintaining data integrity, which is critical for therapeutic success and regulatory approval in an increasingly regulated and innovation-focused global industry.
Cell & Gene Therapy Bioanalytical Testing Services Market- Segmentation Analysis:
The Global Cell & Gene Therapy Bioanalytical Testing Services Market is segmented on the basis of Product Type, Test Type, Technology, Indication Coverage, End User, and Region.
The market for advanced therapy services is segmented by product type into Cell Therapy, Gene Therapy, and Gene-Modified Cell Therapy. Cell therapy services primarily focus on ensuring the potency, identity, and safety of stem cells and immune cells used in treatments, supporting regenerative medicine and immunotherapy applications. Gene therapy is further divided into ex-vivo and in-vivo approaches, both requiring specialized viral vector assays and transduction efficiency testing to guarantee effective gene delivery and expression. Gene-modified cell therapies, including CAR T-cell, CAR-NK cell, and TCR-T cell therapies, demand rigorous bioanalytical validation to confirm engineered immune responses and therapeutic efficacy. According to the U.S. Food and Drug Administration (FDA), the number of approved gene and cell therapy products has significantly increased in recent years, with regulatory frameworks evolving to support these complex therapies, thereby driving demand for comprehensive testing services across these categories.
In addition, the market is categorized by test type into bioavailability and bioequivalence studies, pharmacokinetic and pharmacodynamic testing, biomarker testing, non-clinical studies, tissue bioanalysis, and miscellaneous supportive tests. Bioavailability and bioequivalence studies are essential to ensure therapeutic consistency and regulatory compliance, particularly for novel biologics. Pharmacokinetic testing assesses drug absorption and distribution, while pharmacodynamic testing evaluates drug action and biological effects. Biomarker testing plays a critical role in monitoring treatment efficacy and patient response, supporting personalized medicine initiatives. Non-clinical and tissue bioanalysis provide vital preclinical data that inform clinical trial design and safety evaluations. Miscellaneous and other tests offer case-specific analytical insights necessary for regulatory submissions and product validation. The National Institutes of Health (NIH) highlights the growing investment in advanced testing methodologies as pivotal to accelerating the development and approval of innovative gene and cell therapies globally.
Cell & Gene Therapy Bioanalytical Testing Services Market- Geographical Insights
The Cell & Gene Therapy Bioanalytical Testing Services Market exhibits notable regional differences, shaped by the pace of therapy development, regulatory environments, and R&D investment across various geographies. North America dominates the market, driven by its advanced biotechnology clusters, robust government support, and early adoption of cutting-edge therapies. The U.S., in particular, benefits from a dense network of gene and cell therapy developers and regulatory incentives such as the FDA’s accelerated approval pathways, which foster rapid clinical growth. Europe closely follows, with countries like Germany, the UK, and the Netherlands investing heavily in GMP-certified laboratories and national initiatives focused on advancing cell therapy. Meanwhile, the Asia-Pacific region is rapidly emerging as a key player, led by China, South Korea, and Japan, where government-backed biotech parks and expanding clinical infrastructure are fueling market expansion. Additionally, growing outsourcing trends in India and Singapore are transforming the regional landscape, positioning Asia as a strategic hub for cost-effective and high-quality bioanalytical testing services
Cell & Gene Therapy Bioanalytical Testing Services Market- Competitive Landscape:
The competitive landscape of the Cell & Gene Therapy Bioanalytical Testing Services Market features a diverse mix of global contract research organizations (CROs), specialized testing laboratories, and emerging biotech service providers dedicated to advancing analytical capabilities for complex biologics. Leading companies are heavily investing in cutting-edge facilities, GLP/GMP-certified labs, and proprietary assay platforms to address the increasing regulatory and scientific demands. Collaborations between therapy developers and CROs are on the rise, aiming to streamline development timelines and ensure regulatory compliance from preclinical stages through clinical trials. Market players are broadening their service offerings to include customized potency assays, biodistribution studies, vector characterization, and next-generation sequencing-based analytics. Additionally, academic and hospital-affiliated laboratories play a crucial role in early-stage method development and standardization efforts. Competition is intensifying in regions like Asia-Pacific, where local firms are scaling up capabilities to support global clinical trials. In this dynamic market, flexibility, regulatory expertise, and rapid turnaround times serve as key differentiators.
Recent Developments:
- In August 2024, SGS launched specialized bioanalytical testing services for cell and gene therapies in North America, providing comprehensive support from discovery through Phase 3 clinical trials at its Hudson, New Hampshire facility, enhancing global capabilities for advanced therapeutic development and regulatory compliance.
- In March 2025, Bharat Biotech inaugurated its first cell and gene therapy facility in Telangana with a $75 million investment, targeting novel therapies for oncology and rare diseases by 2028, with a focus on affordability and expanding beyond vaccines.
- In April 2025, Cell Therapies and Xellera Therapeutics formed a strategic partnership to accelerate cell and gene therapy access across Asia-Pacific, concentrating on GMP manufacturing, regulatory support, and collaborative innovation in Australia and Hong Kong to improve patient care and facilitate market entry.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL CELL & GENE THERAPY BIOANALYTICAL TESTING SERVICES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Alliance Pharma
- BioAgilytix Labs
- Charles River Laboratories
- Clean Cells
- Covance Inc.
- Eurofins Scientific
- ICON plc
- Intertek Group Plc
- IQVIA, Inc.
- KCAS Bioanalytical Services
- Laboratory Corporation of America Holdings
- Pharmaceutical Product Development, Inc. (Thermo Fisher Scientific Inc.)
- Pharmaron
- Prolytix
- SGS SA
- Syneos Health
- Others
GLOBAL CELL & GENE THERAPY BIOANALYTICAL TESTING SERVICES MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032
- Cell Therapy
- Gene Therapy
- Ex-vivo
- In-vivo
- Gene-Modified Cell Therapy
- CAR T-cell therapies
- CAR-NK cell therapy
- TCR-T cell therapy
GLOBAL CELL & GENE THERAPY BIOANALYTICAL TESTING SERVICES MARKET, BY TEST TYPE- MARKET ANALYSIS, 2019 - 2032
- Bioavailability & Bioequivalence Studies
- Pharmacokinetic Testing
- Pharmacodynamic Testing
- Biomarker Testing
- Non-clinical
- Tissue Bioanalysis
- Miscellaneous
- Others
GLOBAL CELL & GENE THERAPY BIOANALYTICAL TESTING SERVICES MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032
- PCR
- ELISA
- Next-Generation Sequencing (NGS)
- Flow Cytometry
- Others
GLOBAL CELL & GENE THERAPY BIOANALYTICAL TESTING SERVICES MARKET, BY INDICATION COVERAGE- MARKET ANALYSIS, 2019 - 2032
- Oncology Cancer
- Infectious Diseases
- Neurological disorders
- Cardiovascular Disorders
- Gastrointestinal Diseases
- Autoimmune Diseases
- Rare Diseases
- Others
GLOBAL CELL & GENE THERAPY BIOANALYTICAL TESTING SERVICES MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032
- Biotechnology & Pharmaceutical Companies
- Academic & Research Institutes
- Contract Research Organizations (CROs)
GLOBAL CELL & GENE THERAPY BIOANALYTICAL TESTING SERVICES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Cell & Gene Therapy Bioanalytical Testing Services Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Cell & Gene Therapy Bioanalytical Testing Services Market Snippet by Product Type
2.1.2. Cell & Gene Therapy Bioanalytical Testing Services Market Snippet by Test Type
2.1.3. Cell & Gene Therapy Bioanalytical Testing Services Market Snippet by Technology
2.1.4. Cell & Gene Therapy Bioanalytical Testing Services Market Snippet by Indication Coverage
2.1.5. Cell & Gene Therapy Bioanalytical Testing Services Market Snippet by End User
2.1.6. Cell & Gene Therapy Bioanalytical Testing Services Market Snippet by Country
2.1.7. Cell & Gene Therapy Bioanalytical Testing Services Market Snippet by Region
2.2. Competitive Insights
3. Cell & Gene Therapy Bioanalytical Testing Services Key Market Trends
3.1. Cell & Gene Therapy Bioanalytical Testing Services Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Cell & Gene Therapy Bioanalytical Testing Services Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Cell & Gene Therapy Bioanalytical Testing Services Market Opportunities
3.4. Cell & Gene Therapy Bioanalytical Testing Services Market Future Trends
4. Cell & Gene Therapy Bioanalytical Testing Services Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Cell & Gene Therapy Bioanalytical Testing Services Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Cell & Gene Therapy Bioanalytical Testing Services Market Landscape
6.1. Cell & Gene Therapy Bioanalytical Testing Services Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Cell & Gene Therapy Bioanalytical Testing Services Market – By Product Type
7.1. Overview
7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
7.1.2. Cell Therapy
7.1.3. Gene Therapy
7.1.3.1. Ex-vivo
7.1.3.2. In-vivo
7.1.4. Gene-Modified Cell Therapy
7.1.4.1. CAR T-cell therapies
7.1.4.2. CAR-NK cell therapy
7.1.4.3. TCR-T cell therapy
8. Cell & Gene Therapy Bioanalytical Testing Services Market – By Test Type
8.1. Overview
8.1.1. Segment Share Analysis, By Test Type, 2024 & 2032 (%)
8.1.2. Bioavailability & Bioequivalence Studies
8.1.3. Pharmacokinetic Testing
8.1.4. Pharmacodynamic Testing
8.1.5. Biomarker Testing
8.1.6. Non-clinical
8.1.7. Tissue Bioanalysis
8.1.8. Miscellaneous
8.1.9. Others
9. Cell & Gene Therapy Bioanalytical Testing Services Market – By Technology
9.1. Overview
9.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
9.1.2. PCR
9.1.3. ELISA
9.1.4. Next-Generation Sequencing (NGS)
9.1.5. Flow Cytometry
9.1.6. Others
10. Cell & Gene Therapy Bioanalytical Testing Services Market – By Indication Coverage
10.1. Overview
10.1.1. Segment Share Analysis, By Indication Coverage, 2024 & 2032 (%)
10.1.2. Oncology Cancer
10.1.3. Infectious Diseases
10.1.4. Neurological disorders
10.1.5. Cardiovascular Disorders
10.1.6. Gastrointestinal Diseases
10.1.7. Autoimmune Diseases
10.1.8. Rare Diseases
10.1.9. Others
11. Cell & Gene Therapy Bioanalytical Testing Services Market – By End User
11.1. Overview
11.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
11.1.2. Biotechnology & Pharmaceutical Companies
11.1.3. Academic & Research Institutes
11.1.4. Contract Research Organizations (CROs)
12. Cell & Gene Therapy Bioanalytical Testing Services Market– By Geography
12.1. Introduction
12.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
12.2. North America
12.2.1. Overview
12.2.2. Cell & Gene Therapy Bioanalytical Testing Services Key Manufacturers in North America
12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.2.5. North America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.2.6. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.2.7. North America Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
12.2.8. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.2.9. U.S.
12.2.9.1. Overview
12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.2.9.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.2.9.4. U.S. Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.2.9.5. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.2.9.6. U.S. Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
12.2.9.7. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.2.10. Canada
12.2.10.1. Overview
12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.2.10.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.2.10.4. Canada Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.2.10.5. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.2.10.6. Canada Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
12.2.10.7. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3. Europe
12.3.1. Overview
12.3.2. Cell & Gene Therapy Bioanalytical Testing Services Key Manufacturers in Europe
12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.5. Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.3.6. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.7. Europe Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
12.3.8. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.9. Germany
12.3.9.1. Overview
12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.9.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.9.4. Germany Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.3.9.5. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.9.6. Germany Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
12.3.9.7. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.10. UK
12.3.10.1. Overview
12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.10.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.10.4. UK Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.3.10.5. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.10.6. UK Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
12.3.10.7. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.11. France
12.3.11.1. Overview
12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.11.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.11.4. France Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.3.11.5. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.11.6. France Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
12.3.11.7. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.12. Italy
12.3.12.1. Overview
12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.12.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.12.4. Italy Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.3.12.5. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.12.6. Italy Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
12.3.12.7. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.13. Spain
12.3.13.1. Overview
12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.13.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.13.4. Spain Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.3.13.5. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.13.6. Spain Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
12.3.13.7. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.14. The Netherlands
12.3.14.1. Overview
12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.14.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.14.4. The Netherlands Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.3.14.5. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.14.6. The Netherlands Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
12.3.14.7. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.15. Sweden
12.3.15.1. Overview
12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.15.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.15.4. Sweden Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.3.15.5. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.15.6. Sweden Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
12.3.15.7. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.16. Russia
12.3.16.1. Overview
12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.16.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.16.4. Russia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.3.16.5. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.16.6. Russia Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
12.3.16.7. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.17. Poland
12.3.17.1. Overview
12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.17.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.17.4. Poland Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.3.17.5. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.17.6. Poland Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
12.3.17.7. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.18. Rest of Europe
12.3.18.1. Overview
12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.18.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.18.4. Rest of the Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.3.18.5. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.18.6. Rest of the Europe Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
12.3.18.7. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4. Asia Pacific (APAC)
12.4.1. Overview
12.4.2. Cell & Gene Therapy Bioanalytical Testing Services Key Manufacturers in Asia Pacific
12.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.5. APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.4.6. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.7. APAC Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
12.4.8. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.9. China
12.4.9.1. Overview
12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.9.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.9.4. China Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.4.9.5. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.9.6. China Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
12.4.9.7. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.10. India
12.4.10.1. Overview
12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.10.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.10.4. India Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.4.10.5. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.10.6. India Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
12.4.10.7. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.11. Japan
12.4.11.1. Overview
12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.11.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.11.4. Japan Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.4.11.5. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.11.6. Japan Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
12.4.11.7. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.12. South Korea
12.4.12.1. Overview
12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.12.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.12.4. South Korea Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.4.12.5. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.12.6. South Korea Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
12.4.12.7. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.13. Australia
12.4.13.1. Overview
12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.13.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.13.4. Australia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.4.13.5. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.13.6. Australia Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
12.4.13.7. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.14. Indonesia
12.4.14.1. Overview
12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.14.4. Indonesia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.4.14.5. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.14.6. Indonesia Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
12.4.14.7. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.15. Thailand
12.4.15.1. Overview
12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.15.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.15.4. Thailand Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.4.15.5. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.15.6. Thailand Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
12.4.15.7. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.16. Philippines
12.4.16.1. Overview
12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.16.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.16.4. Philippines Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.4.16.5. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.16.6. Philippines Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
12.4.16.7. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.17. Rest of APAC
12.4.17.1. Overview
12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.17.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.17.4. Rest of APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.4.17.5. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.17.6. Rest of APAC Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5. Latin America (LATAM)
12.5.1. Overview
12.5.2. Cell & Gene Therapy Bioanalytical Testing Services Key Manufacturers in Latin America
12.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.5. LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.5.6. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.7. LATAM Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
12.5.8. LATAM Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.9. Brazil
12.5.9.1. Overview
12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.9.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.9.4. Brazil Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.5.9.5. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.9.6. Brazil Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
12.5.9.7. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.10. Mexico
12.5.10.1. Overview
12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.10.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.10.4. Mexico Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.5.10.5. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.10.6. Mexico Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
12.5.10.7. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.11. Argentina
12.5.11.1. Overview
12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.11.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.11.4. Argentina Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.5.11.5. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.11.6. Argentina Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
12.5.11.7. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.12. Colombia
12.5.12.1. Overview
12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.12.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.12.4. Colombia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.5.12.5. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.12.6. Colombia Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
12.5.12.7. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.13. Rest of LATAM
12.5.13.1. Overview
12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.13.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.13.4. Rest of LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.5.13.5. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.13.6. Rest of LATAM Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6. Middle East and Africa
12.6.1. Overview
12.6.2. Cell & Gene Therapy Bioanalytical Testing Services Key Manufacturers in Middle East and Africa
12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.5. Middle East and Africa Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.6.6. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.7. Middle East and Africa Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.9. Saudi Arabia
12.6.9.1. Overview
12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.9.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.9.4. Saudi Arabia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.6.9.5. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.9.6. Saudi Arabia Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.10. United Arab Emirates
12.6.10.1. Overview
12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.10.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.10.4. United Arab Emirates Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.6.10.5. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.10.6. United Arab Emirates Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.11. Israel
12.6.11.1. Overview
12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.11.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.11.4. Israel Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.6.11.5. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.11.6. Israel Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
12.6.11.7. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.12. Turkey
12.6.12.1. Overview
12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.12.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.12.4. Turkey Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.6.12.5. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.12.6. Turkey Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
12.6.12.7. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.13. Algeria
12.6.13.1. Overview
12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.13.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.13.4. Algeria Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.6.13.5. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.13.6. Algeria Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
12.6.13.7. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.14. Egypt
12.6.14.1. Overview
12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.14.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.14.4. Egypt Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.6.14.5. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.14.6. Egypt Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
12.6.14.7. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.15. Rest of MEA
12.6.15.1. Overview
12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.15.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.15.4. Rest of MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.6.15.5. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.15.6. Rest of MEA Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13. Key Vendor Analysis- Cell & Gene Therapy Bioanalytical Testing Services Industry
13.1. Competitive Dashboard
13.1.1. Competitive Benchmarking
13.1.2. Competitive Positioning
13.2. Company Profiles
13.2.1. Alliance Pharma
13.2.2. BioAgilytix Labs
13.2.3. Charles River Laboratories
13.2.4. Clean Cells
13.2.5. Covance Inc.
13.2.6. Eurofins Scientific
13.2.7. ICON plc
13.2.8. Intertek Group Plc
13.2.9. IQVIA, Inc.
13.2.10. KCAS Bioanalytical Services
13.2.11. Laboratory Corporation of America Holdings
13.2.12. Pharmaceutical Product Development, Inc. (Thermo Fisher Scientific Inc.)
13.2.13. Pharmaron
13.2.14. Prolytix
13.2.15. SGS SA
13.2.16. Syneos Health
13.2.17. Others
14. 360 Degree Analyst View
15. Appendix
15.1. Research Methodology
15.2. References
15.3. Abbreviations
15.4. Disclaimer
15.5. Contact Us
